Solid pharmaceutical dosage forms

Porter CS, Bruno CH. Coating of pharmaceutical solid-dosage forms. In Lieberman HA, Lachman L, Schwartz JB, eds. Pharmaceutical Dosage Forms Tablets. Yol. 13. New York Marcel Dekker, Inc., 1990 77-160. [Pg.194]

T. Kubala, B. Gamblhir, and J. I. Borst, A specific stability indicating HPLC method to determine diclofenac in raw materials and pharmaceutical solid dosage forms, Drug Dev. Ind. Pharm, 19 749(1993). [Pg.234]

In the pharmaceutical solid dosage form development process, compaction simulators can be used throughout the life of a compound. Royce and coworkers categorized the lifecycle of a compound into three phases (1). [Pg.461]

Guo J-H, Skinner GW, Harcum WW, et al. Application of near-infrared spectroscopy in the pharmaceutical solid dosage form. Drag Dev Ind Pharm 1999 25(12) 1267-1270. [Pg.415]

Until recently, sodium starch glycolate has been used exclusively as a disintegrant in pharmaceutical solid dosage forms. Since it was found that the manufacturing process can be modified, specific SSG grades are produced for different new applications (Tab. 5.4). [Pg.51]

Chem. Descrip. Methacrylic acid copolymer system Uses Enteric coating for pharmaceutical solid dosage forms such as tablets, granules, and beads... [Pg.18]

Geria, T. Hong, W.H. Daly, R.E. Improved high-performance liquid chromatr aphic assay of erythromycin in pharmaceutical solid dosage forms. J.Chromatogr., 1987,396, 191—198... [Pg.556]

FROM MOLECULAR AND CRYSTALLOGRAPHIC STRUCTURE TO THE RATIONAL DESIGN OF PHARMACEUTICAL SOLID DOSAGE FORMS... [Pg.175]

H. Mark, G. E. Ritchie, R. W. Roller, E. W. Ciurczak, C. Tso, and S. A. MacDonald, Validation of a Near-Infrared Transmission Spectroscopic Procedure. Part A. Validation Protocols, /. Pharm. Biomed. Anal, 28,251 (2002). G. E. Ritchie, R. W. Roller, E. W. Ciurczak, H. Mark, C. Tso, and S. A. MacDonald, Validation of a Near-Infrared Transmission Spectroscopic Procedure. Part B. Application to Alternate Content Uniformity and Release Assay Methods for Pharmaceutical Solid Dosage Forms, /. Pharm. Biomed. Anal, 29,159 (2002). M. Blanco, M. Bautista, and M. Alcala, API Determination by NIR Spectroscopy across Pharmaceutical Production Process, AAPS PharmSciTech, 9,1130 (2008). A. Peinado, J. Hammond, and A. Scott, Development, Validation and Transfer of a Near Infrared Method to Determine In-Line the End Point of a Fluidised Drying Process for Commercial Production Batches of an Approved Oral Solid Dose Pharmaceutical Product, /. Pharm. Biomed. Anal, 54,13 (2011). [Pg.115]

Mohrle R. Effervescent tablets. Lieberman HA, Lachman L, eds. Pharmaceutical Solid Dosage Forms. Vol. 1. New York Marcel Dekker, 1980 225-258. http //www.desiccantcity.com/CASE HISTORIES/Historyl l.htm. [Pg.384]

G. E. Ritchie, R. W. Roller, E. W. Ciurczak, H. Mark, C. Tso, S. A. MacDonald. Validation of a near-infrared transmission spectroscopic procedure. Part B Application to alternate content uniformity and release assay methods for pharmaceutical solid dosage forms. J Pharm Biomed Anal 29 159—171, 2002. [Pg.106]

Zeitier, J.A. and Gladden, L.F. (2009) In vitro tomography and non-destructive imaging at depth of pharmaceutical solid dosage forms. Eur. J Pharm. Biopharm., 71 (1), 2-22. [Pg.474]

Big Chemical Encyclopedia

Chemical substances, components, reactions, process design ...